Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1282

1.

Predictors of enucleation in Coats disease: analysis of 259 eyes of 259 patients at a single center.

Udyaver S, Dalvin LA, Lim LS, Mazloumi M, Atalay HT, Khoo CTL, Shields JA, Shields CL.

J AAPOS. 2019 Sep 12. pii: S1091-8531(19)30479-3. doi: 10.1016/j.jaapos.2019.05.015. [Epub ahead of print]

PMID:
31521848
2.

Conjunctival Melanocytic Nevi With Granular Cell Change.

Eiger-Moscovich M, Eagle RC Jr, Lally SE, Shields CL, Shields JA, Langer PD, Sheehan J, Milman T.

Arch Pathol Lab Med. 2019 Aug 30. doi: 10.5858/arpa.2019-0053-OA. [Epub ahead of print]

PMID:
31469587
3.

VITREOUS AND PRERETINAL SEEDING AFTER TRANSVITREAL FINE NEEDLE ASPIRATION BIOPSY OF CHOROIDAL MELANOMA.

Mashayekhi A, Shields CL, Eagle RC Jr, Shields JA.

Retin Cases Brief Rep. 2019 Aug 9. doi: 10.1097/ICB.0000000000000905. [Epub ahead of print]

PMID:
31403972
4.

Uveal Metastasis Based on Patient Sex in 2214 Tumors of 1111 Patients. A Comparison of Female Versus Male Clinical Features and Outcomes.

Welch RJ, Malik K, Considine SP, Acaba-Berrocal LA, Selzer EB, Newman JH, Shields JA, Shields CL.

Asia Pac J Ophthalmol (Phila). 2019 Jul-Aug;8(4):298-303. doi: 10.1097/APO.0000000000000247.

PMID:
31373911
5.

Factors Predictive of Subretinal Fluid Resolution in Coats Disease: Analysis of 177 Eyes in 177 Patients at a Single Center.

Khoo CTL, Dalvin LA, Lim LS, Mazloumi M, Atalay HT, Udyaver S, Shields JA, Shields CL.

Asia Pac J Ophthalmol (Phila). 2019 Jul-Aug;8(4):290-297. doi: 10.1097/APO.0000000000000246.

PMID:
31356365
6.

Visual acuity outcomes in Coats disease by classification stage in 160 patients.

Shields CL, Udyaver S, Dalvin LA, Lim LS, Atalay HT, Khoo C, Mazloumi M, Shields JA.

Br J Ophthalmol. 2019 Jun 8. pii: bjophthalmol-2019-314363. doi: 10.1136/bjophthalmol-2019-314363. [Epub ahead of print]

PMID:
31177186
7.

Coats disease in 351 eyes: Analysis of features and outcomes over 45 years (by decade) at a single center.

Shields CL, Udyaver S, Dalvin LA, Lim LS, Atalay HT, L Khoo CT, Mazloumi M, Shields JA.

Indian J Ophthalmol. 2019 Jun;67(6):772-783. doi: 10.4103/ijo.IJO_449_19.

8.

Coats disease: An overview of classification, management and outcomes.

Sen M, Shields CL, Honavar SG, Shields JA.

Indian J Ophthalmol. 2019 Jun;67(6):763-771. doi: 10.4103/ijo.IJO_841_19. Review.

9.

Intraocular medulloepithelioma - A review of clinical features, DICER 1 mutation, and management.

Tadepalli SH, Shields CL, Shields JA, Honavar SG.

Indian J Ophthalmol. 2019 Jun;67(6):755-762. doi: 10.4103/ijo.IJO_845_19. Review.

10.

Authors' Reply.

Pennington JD, Welch RJ, Lally SE, Shields JA, Eagle RC, Shields CL.

Middle East Afr J Ophthalmol. 2019 Jan-Mar;26(1):53. doi: 10.4103/meajo.MEAJO_294_18. No abstract available.

11.

Visual improvement in amblyopic eye following treatment-induced vision loss in dominant eye with uveal melanoma.

Vagge A, Shields CL, Shields JA, Pointdujour-Lim R, Schnall B.

Br J Ophthalmol. 2019 May 16. pii: bjophthalmol-2018-313505. doi: 10.1136/bjophthalmol-2018-313505. [Epub ahead of print]

PMID:
31097438
12.

VON HIPPEL-LINDAU DISEASE: Update on Pathogenesis and Systemic Aspects.

Aronow ME, Wiley HE, Gaudric A, Krivosic V, Gorin MB, Shields CL, Shields JA, Jonasch EW, Singh AD, Chew EY.

Retina. 2019 May 14. doi: 10.1097/IAE.0000000000002555. [Epub ahead of print]

PMID:
31095066
13.

Conjunctival Myxoid Lesions: Clinical-Pathologic Multiparametric Analysis, Including Molecular Genetics (An American Ophthalmological Society Thesis).

Milman T, Salomao DR, Ida CM, Capiz Correa DR, Grossniklaus HE, Zhang Q, Hamershock RA, Shields C, Shields JA, Raber I, Rapuano CJ, Patel R, Eagle RC Jr.

Am J Ophthalmol. 2019 Sep;205:115-131. doi: 10.1016/j.ajo.2019.04.027. Epub 2019 May 10.

PMID:
31078543
14.

Amelanotic Ciliochoroidal Melanoma in a Patient with Oculocutaneous Albinism.

Sivalingam MD, Dalvin LA, Shields CL, Mashayekhi A, Shields JA.

Ocul Oncol Pathol. 2019 Apr;5(3):182-185. doi: 10.1159/000490913. Epub 2018 Sep 3.

15.

Choroidal amelanotic tumours: clinical differentiation of benign from malignant lesions in 5586 cases.

Welch RJ, Newman JH, Honig SE, Mayro EL, McGarrey M, Graf AE, Selzer EB, Acaba-Berrocal LA, Considine SP, Malik K, Shields JA, Shields CL.

Br J Ophthalmol. 2019 Apr 25. pii: bjophthalmol-2018-313680. doi: 10.1136/bjophthalmol-2018-313680. [Epub ahead of print]

PMID:
31023712
16.

CHOROIDAL NEVUS TRANSFORMATION INTO MELANOMA PER MILLIMETER INCREMENT IN THICKNESS USING MULTIMODAL IMAGING IN 2355 CASES: The 2019 Wendell L. Hughes Lecture.

Shields CL, Dalvin LA, Yu MD, Ancona-Lezama D, Di Nicola M, Williams BK, Lucio-Alvarez JA, Ang SM, Maloney SM, Welch RJ, Shields JA.

Retina. 2019 Mar 15. doi: 10.1097/IAE.0000000000002508. [Epub ahead of print]

PMID:
30883534
17.

Small choroidal melanoma: detection with multimodal imaging and management with plaque radiotherapy or AU-011 nanoparticle therapy.

Shields CL, Lim LS, Dalvin LA, Shields JA.

Curr Opin Ophthalmol. 2019 May;30(3):206-214. doi: 10.1097/ICU.0000000000000560. Review.

PMID:
30844944
18.

Primary Cutaneous Angiosarcoma of the Eyelid: A Diagnostic and Therapeutic Challenge.

Milman T, Shields CL, Brooks JSJ, Lally SE, Shields JA, Tuluc M, Eagle RC Jr.

Ocul Oncol Pathol. 2018 Jun;4(4):230-235. doi: 10.1159/000485427. Epub 2018 Jan 12.

19.

CHOROIDAL NEVUS IMAGING FEATURES IN 3,806 CASES AND RISK FACTORS FOR TRANSFORMATION INTO MELANOMA IN 2,355 CASES: The 2020 Taylor R. Smith and Victor T. Curtin Lecture.

Shields CL, Dalvin LA, Ancona-Lezama D, Yu MD, Di Nicola M, Williams BK Jr, Lucio-Alvarez JA, Ang SM, Maloney S, Welch RJ, Shields JA.

Retina. 2018 Dec 31. doi: 10.1097/IAE.0000000000002440. [Epub ahead of print]

PMID:
30608349
20.

Combination of multimodal imaging features predictive of choroidal nevus transformation into melanoma.

Dalvin LA, Shields CL, Ancona-Lezama DA, Yu MD, Di Nicola M, Williams BK Jr, Lucio-Alvarez JA, Ang SM, Maloney SM, Welch RJ, Shields JA.

Br J Ophthalmol. 2019 Oct;103(10):1441-1447. doi: 10.1136/bjophthalmol-2018-312967. Epub 2018 Dec 6.

PMID:
30523045
21.

Episcleral racemose hemangioma.

Lim LA, Brower P, Shields JA, Shields CL.

J AAPOS. 2019 Apr;23(2):111-113. doi: 10.1016/j.jaapos.2018.10.007. Epub 2018 Nov 20.

PMID:
30468851
22.

Plaque Radiotherapy for Medulloepithelioma in 6 Cases From a Single Center.

Ang SM, Dalvin LA, Emrich J, Komarnicky L, Shields JA, Shields CL.

Asia Pac J Ophthalmol (Phila). 2019 Jan-Feb;8(1):30-35. doi: 10.22608/APO.2018257. Epub 2018 Oct 30.

PMID:
30375203
23.

UVEAL METASTASIS BASED ON PATIENT AGE IN 1,111 PATIENTS: Comparison of Clinical Features and Outcomes Per Age Category.

Shields CL, Acaba-Berrocal LA, Selzer EB, Mayro EL, Newman JH, Malik K, Welch RJ, Shields JA.

Retina. 2018 Oct 16. doi: 10.1097/IAE.0000000000002364. [Epub ahead of print]

PMID:
30334925
24.

Visual Outcome and Millimeter Incremental Risk of Metastasis in 1780 Patients With Small Choroidal Melanoma Managed by Plaque Radiotherapy.

Shields CL, Sioufi K, Srinivasan A, Di Nicola M, Masoomian B, Barna LE, Bekerman VP, Say EAT, Mashayekhi A, Emrich J, Komarnicky L, Shields JA.

JAMA Ophthalmol. 2018 Dec 1;136(12):1325-1333. doi: 10.1001/jamaophthalmol.2018.3881. Erratum in: JAMA Ophthalmol. 2019 Jan 17;:.

PMID:
30267070
25.

Comparison of posterior lamellar resection versus lumpectomy for initial management of localized tarsal conjunctival sebaceous carcinoma in 54 cases.

Lally SE, Rao R, Shields JA, Shields CL.

Indian J Ophthalmol. 2018 Sep;66(9):1295-1300. doi: 10.4103/ijo.IJO_239_18.

26.

Iris Melanoma in a Child Simulating Juvenile Xanthogranuloma.

Shields JA, Shields CL, Lally SE, Milman T, Eagle RC.

Middle East Afr J Ophthalmol. 2018 Apr-Jun;25(2):115-117. doi: 10.4103/meajo.MEAJO_7_18.

27.

Botryoid Rhabdomyosarcoma of the Conjunctiva in a Young Boy.

Pennington JD, Welch RJ, Lally SE, Shields JA, Eagle RC, Shields CL.

Middle East Afr J Ophthalmol. 2018 Apr-Jun;25(2):111-114. doi: 10.4103/meajo.MEAJO_8_18.

28.

Uveal Metastasis: Clinical Features and Survival Outcome of 2214 Tumors in 1111 Patients Based on Primary Tumor Origin.

Shields CL, Welch RJ, Malik K, Acaba-Berrocal LA, Selzer EB, Newman JH, Mayro EL, Constantinescu AB, Spencer MA, McGarrey MP, Knapp AN, Graf AE, Altman AJ, Considine SP, Shields JA.

Middle East Afr J Ophthalmol. 2018 Apr-Jun;25(2):81-90. doi: 10.4103/meajo.MEAJO_6_18.

29.

Iris Microhemangiomatosis: Clinical, Fluorescein Angiography, and Optical Coherence Tomography Angiography Features in 14 Consecutive Patients.

Williams BK Jr, Di Nicola M, Ferenczy S, Shields JA, Shields CL.

Am J Ophthalmol. 2018 Dec;196:18-25. doi: 10.1016/j.ajo.2018.08.011. Epub 2018 Aug 15.

PMID:
30118687
30.

Bilateral uveal melanoma: hunting for the source.

Shields CL, Masoomian B, Shields JA.

Clin Exp Ophthalmol. 2018 Jul;46(5):459-461. doi: 10.1111/ceo.13344. No abstract available.

PMID:
30003677
31.

GROWTH OF PRESUMED CHOROIDAL NEVUS INTO MELANOMA OVER 4 YEARS IN BAP1 TUMOR PREDISPOSITION SYNDROME.

Masoomian B, Shields CL, Mashayekhi A, Ganguly A, Shields JA.

Retin Cases Brief Rep. 2018 Jul 6. doi: 10.1097/ICB.0000000000000772. [Epub ahead of print]

PMID:
29994997
32.

Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma.

Masoomian B, Shields JA, Shields CL.

J Curr Ophthalmol. 2018 Mar 22;30(2):102-109. doi: 10.1016/j.joco.2018.02.005. eCollection 2018 Jun. Review.

33.

Distinguishing midzonal iris pigment epithelial cyst from adenoma and ciliary body melanoma.

Mayro EL, Surakiatchanukul T, Shields JA, Shields CL.

Oman J Ophthalmol. 2018 May-Aug;11(2):161-163. doi: 10.4103/ojo.OJO_226_2017.

34.

Advanced Midzonal Iris Pigment Epithelial Cyst Managed by Aspiration Deflation.

Shields JA, Fallon SJ, Shields CN, Lally SE, Shields CL.

Ocul Oncol Pathol. 2018 Apr;4(3):182-185. doi: 10.1159/000481405. Epub 2017 Nov 9.

35.

Cytogenetic results of choroidal nevus growth into melanoma in 55 consecutive cases.

Shields CL, Pefkianaki M, Mashayekhi A, Shields JA, Ganguly A.

Saudi J Ophthalmol. 2018 Jan-Mar;32(1):28-32. doi: 10.1016/j.sjopt.2018.02.004. Epub 2018 Feb 15.

36.

CHECKPOINT INHIBITOR IMMUNE THERAPY: Systemic Indications and Ophthalmic Side Effects.

Dalvin LA, Shields CL, Orloff M, Sato T, Shields JA.

Retina. 2018 Jun;38(6):1063-1078. doi: 10.1097/IAE.0000000000002181. Review.

PMID:
29689030
37.

By Sleight of Hand, Prognosis Determined-Even for Small Choroidal Melanoma.

Shields CL, Mashayekhi A, Shields JA.

JAMA Ophthalmol. 2018 May 1;136(5):488-489. doi: 10.1001/jamaophthalmol.2018.0196. No abstract available.

PMID:
29596557
38.

Uveal Melanoma Associated With Myotonic Dystrophy: A Report of 6 Cases.

Dalvin LA, Shields CL, Pulido JS, Sioufi K, Cohen V, Shields JA.

JAMA Ophthalmol. 2018 May 1;136(5):543-547. doi: 10.1001/jamaophthalmol.2018.0554.

39.

LARGE UVEAL MELANOMA (≥10 MM THICKNESS): Clinical Features and Millimeter-by-Millimeter Risk of Metastasis in 1311 Cases. The 2018 Albert E. Finley Lecture.

Shields CL, Sioufi K, Robbins JS, Barna LE, Harley MR, Lally SE, Say EAT, Mashayekhi A, Shields JA.

Retina. 2018 Oct;38(10):2010-2022. doi: 10.1097/IAE.0000000000002144.

PMID:
29528980
40.

Caruncular Oncocytoma Mimicking Malignant Melanoma.

Surakiatchanukul T, Sioufi K, Pointdujour-Lim R, Eagle RC Jr, Shields JA, Shields CL.

Ocul Oncol Pathol. 2017 Nov;3(4):320-323. doi: 10.1159/000468524. Epub 2017 May 6.

41.

Intravitreal Aflibercept as Rescue Therapy for Post-Radiation Cystoid Macular Edema Resistant to Intravitreal Bevacizumab: Outcomes at 1 Year.

Khan MA, Mashayekhi A, Shields JA, Shields CL.

Ocul Oncol Pathol. 2017 Nov;3(4):313-319. doi: 10.1159/000452163. Epub 2017 May 6.

42.

Iris Melanoma Outcomes Based on the American Joint Committee on Cancer Classification (Eighth Edition) in 432 Patients.

Shields CL, Di Nicola M, Bekerman VP, Kaliki S, Alarcon C, Fulco E, Shields JA.

Ophthalmology. 2018 Jun;125(6):913-923. doi: 10.1016/j.ophtha.2017.11.040. Epub 2018 Jan 17.

PMID:
29342436
43.

INVISIBLE, HONEYCOMB-LIKE, CAVITARY RETINAL ASTROCYTIC HAMARTOMA.

Mellen PL, Sioufi K, Shields JA, Shields CL.

Retin Cases Brief Rep. 2017 Dec 28. doi: 10.1097/ICB.0000000000000697. [Epub ahead of print]

PMID:
29286955
44.

Optical coherence tomography angiography of iris microhemangiomatosis.

Kang AS, Welch RJ, Sioufi K, Say EAT, Shields JA, Shields CL.

Am J Ophthalmol Case Rep. 2017 Feb 13;6:24-26. doi: 10.1016/j.ajoc.2017.02.003. eCollection 2017 Jun.

45.

High-Dose (2.5 mg) Intravitreal Bevacizumab as Rescue Therapy for Persistent Postradiation Cystoid Macular Edema.

Khan MA, Mashayekhi A, Ferguson K, Shields JA, Shields CL.

Ocul Oncol Pathol. 2017 Sep;3(3):168-175. doi: 10.1159/000448719. Epub 2017 Jan 27.

46.

Uveal effusion syndrome in 104 eyes: Response to corticosteroids - The 2017 Axel C. Hansen lecture.

Shields CL, Roelofs K, Di Nicola M, Sioufi K, Mashayekhi A, Shields JA.

Indian J Ophthalmol. 2017 Nov;65(11):1093-1104. doi: 10.4103/ijo.IJO_752_17.

47.

Mantle-Cell Lymphoma-Taming the Tiger.

Shields CL, Lally SE, Shields JA.

JAMA Ophthalmol. 2017 Dec 1;135(12):1374-1375. doi: 10.1001/jamaophthalmol.2017.4290. No abstract available.

PMID:
29121204
48.

CHOROIDAL MELANOMA IN PHAKOMATOSIS PIGMENTOVASCULARIS WITH KLIPPEL-TRENAUNAY SYNDROME.

Shields CL, Di Nicola M, Pellegrini M, Shields JA.

Retina. 2018 Nov;38(11):2220-2227. doi: 10.1097/IAE.0000000000001856.

PMID:
28937525
49.

Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls.

Valsecchi ME, Orloff M, Sato R, Chervoneva I, Shields CL, Shields JA, Mastrangelo MJ, Sato T.

Ophthalmology. 2018 Feb;125(2):210-217. doi: 10.1016/j.ophtha.2017.08.017. Epub 2017 Sep 19.

PMID:
28935400
50.

HIGH-RISK INTRAOCULAR RETINOBLASTOMA: Comparison Between Asian Indians and Americans From Two Major Referral Centers.

Kaliki S, Shields CL, Eagle RC Jr, Iram S, Shields JA.

Retina. 2018 Oct;38(10):2023-2029. doi: 10.1097/IAE.0000000000001816.

PMID:
28834944

Supplemental Content

Loading ...
Support Center